Icatibant

Icatibant is a pharmaceutical-grade active ingredient classified as a Bradykinin B2 Receptor Antagonist. Mediocon Inc supplies high-purity Icatibant API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

• Selective bradykinin B2 receptor antagonist
• Approved for hereditary angioedema (HAE) attacks
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation

Applications

• Acute attacks of hereditary angioedema (HAE)
• Bradykinin-mediated angioedema
• Subcutaneous injectable formulations
• Rare disease / orphan indication

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings